We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib.
- Authors
Foss, Francine M.; Rubinowitz, Ami; Landry, Marie L.; Isufi, Iris; Gowda, Lohith; Seropian, Stuart; Perreault, Sarah; Shenoi, Sheela V.
- Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) has a high death rate in patients with comorbidities or in an immunocompromised state. We report a mild and attenuated SARS CoV-2 infection in a patient who is 17 months post stem cell transplantation and maintained on the JAK/STAT inhibitor ruxolitinib, a proposed novel therapy for SARS CoV-2 pneumonia.
- Publication
Clinical Lymphoma, Myeloma & Leukemia, 2020, Vol 20, Issue 11, p720
- ISSN
2152-2650
- Publication type
Article
- DOI
10.1016/j.clml.2020.06.014